The use of pemetrexed in advanced non-small cell lung cancer

被引：0
|
作者：
Ng, C. [1 ]
Harris, M. A. [1 ]
Burt, P. A. [1 ]
Sheikh, H. S. [1 ]
Lee, L. [1 ]
Blackhall, F. H. [1 ]
Summers, Y. [1 ]
Taylor, P. [1 ]
Coote, J. [1 ]
Chittalia, A. [1 ]
Califano, R. [1 ]
Bayman, N. [1 ]
机构：
[1] Christie Hosp NHS Trust, Manchester, Lancs, England
来源：
LUNG CANCER | 2014年 / 83卷
关键词：
D O I：
10.1016/S0169-5002(14)70032-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
31
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [41] RETROSPECTIVE ANALYSIS OF PEMETREXED IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
    Kitazaki, Takeshi
    Ogawara, Daiki
    Yamaguchi, Hiroyuki
    Fukuda, Minoru
    Shimada, Midori
    Ikeda, Takaya
    Tomonaga, Nanae
    Soda, Hiroshi
    Nakamura, Yoichi
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S489 - S489
  • [42] Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer
    Lal, R.
    Hillerdal, G. N.
    Shah, R. N. H.
    Crosse, B.
    Thompson, J.
    Nicolson, M.
    Vikstrom, A.
    Potter, V. A.
    Visseren-Grul, C.
    Lorenzo, M.
    D'yachkova, Y.
    Bourayou, N.
    Summers, Y. J.
    LUNG CANCER, 2015, 89 (02) : 154 - 160
  • [43] ECONOMIC EVALUATION OF PEMETREXED IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER IN JAPAN
    Kamae, I
    Nakahara, N.
    Moriwaki, K.
    Enatsu, S.
    Nambu, Y.
    VALUE IN HEALTH, 2010, 13 (07) : A513 - A513
  • [44] Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer
    Cristina Chamizo
    Sandra Zazo
    Manuel Dómine
    Ion Cristóbal
    Jesús García-Foncillas
    Federico Rojo
    Juan Madoz-Gúrpide
    BMC Pulmonary Medicine, 15
  • [45] Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer
    Monnerat, C.
    Le Chevalier, T.
    ANNALS OF ONCOLOGY, 2006, 17 : V86 - V90
  • [46] Phase I/II trial of bortezimib and pemetrexed in patients with advanced non-small cell lung cancer
    Natale, R. B.
    McKinley, M.
    Hilger, J.
    Myers, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] A STUDY OF PEMETREXED MONOTHERAPY IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER WITH IMPAIRED RENAL FUNCTION
    Funaguchi, Norihiko
    Ohno, Yasushi
    Kaito, Daizo
    Yanase, Komei
    Ito, Fumitaka
    Endo, Junki
    Kamiya, Fumihiko
    Morishita, Megumi
    Asano, Masahiro
    Minatoguchi, Shinya
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1160 - S1160
  • [48] Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer
    Chamizo, Cristina
    Zazo, Sandra
    Domine, Manuel
    Cristobal, Ion
    Garcia-Foncillas, Jesus
    Rojo, Federico
    Madoz-Gurpide, Juan
    BMC PULMONARY MEDICINE, 2015, 15
  • [49] COMPARISON OF EGFR-TKIS AND PEMETREXED FOR KOREAN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Lee, J. H.
    Ryu, Y. J.
    Chun, E. M.
    Chang, J. H.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S90 - S90
  • [50] Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
    Fleeman, N.
    Bagust, A.
    McLeod, C.
    Greenhalgh, J.
    Boland, A.
    Dundar, Y.
    Dickson, R.
    Smith, C. Tudur
    Davis, H.
    Green, J.
    Pearson, M.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 47 - 53
12345